Guardian Pharmacy Services, Inc. Increase (Decrease) in Accounts Receivable
Guardian Pharmacy Services, Inc. (GRDN) reported Increase (Decrease) in Accounts Receivable of $4.88 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- Guardian Pharmacy Services, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$6.25M.
- Guardian Pharmacy Services, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $11.13M, a 1005.16% increase year-over-year.
- Guardian Pharmacy Services, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$3.04M, a 137.07% decline year-over-year.
- Guardian Pharmacy Services, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $13.18M, a 517.62% increase year-over-year.
- Guardian Pharmacy Services, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $8.55M, a 66.44% decline from fiscal 2024.
- Guardian Pharmacy Services, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $25.48M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$6.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.88M 10-Q · filed 2026-08-06 | $1.84M derived: sum of 3 quarters · filed 2026-08-06 | $15.02M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $11.13M 10-Q · filed 2026-05-06 | $8.09M derived: sum of 2 quarters · filed 2026-05-06 | $21.27M derived: sum of 3 quarters · filed 2026-05-06 | $18.68M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$3.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $10.14M derived: sum of 2 quarters · filed 2026-03-11 | $7.55M derived: sum of 3 quarters · filed 2026-08-06 | $8.55M 10-K · filed 2026-03-11 |
| 2025-09-30 | $13.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $10.59M derived: sum of 2 quarters · filed 2026-08-06 | $11.59M 10-Q · filed 2025-11-10 | $19.79M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$2.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.59M 10-Q · filed 2026-08-06 | $6.61M derived: sum of 3 quarters · filed 2026-08-06 | $8.75M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.01M 10-Q · filed 2026-05-06 | $9.21M derived: sum of 2 quarters · filed 2026-05-06 | $11.34M derived: sum of 3 quarters · filed 2026-05-06 | $16.95M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $8.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $10.33M derived: sum of 2 quarters · filed 2026-03-11 | $15.94M derived: sum of 3 quarters · filed 2026-03-11 | $25.48M 10-K · filed 2026-03-11 |
| 2024-09-30 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $7.74M derived: sum of 2 quarters · filed 2025-11-10 | $17.29M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $5.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $15.15M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $9.54M 10-Q · filed 2025-05-12 | |||
| 2023-09-30 | $11.96M 10-Q · filed 2024-11-12 |